查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1525456

全球 HLA 分型市場評估：按產品與服務、按技術、按應用、按最終用戶、按地區、機會、預測（2017-2031 年）

HLA Typing Market Assessment, By Products and Services, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 221 Pages | 商品交期: 3-5個工作天內

價格

全球 HLA 分型市場規模預計將從 2023 年的 13.1 億美元增至 2031 年的 21.3 億美元，2024-2031 年預測期間複合年增長率為 6.27%。器官移植需求的不斷增長、遺傳性疾病病例數量的增加、對研究活動的日益關注以及市場主要參與者推出的新產品支持了市場的增長。

Health Resource and Services Administration（HRSA）估計，美國約有 103,223 名男性、女性和兒童在全國移植等待名單上。這種增加促使器官移植病例和 HLA 分型需求的增加。由於遺傳和自體免疫疾病負擔的增加，研究活動不斷增加，全球 HLA 分型市場規模不斷擴大。American Autoimmune 估計約有 5,000 萬美國人患有一種或多種自體免疫疾病。

市場領導者開發的新技術、產品和軟體正在為市場創造利潤豐厚的成長機會。2024 年 6 月，Thermo Fisher Scientific Inc. 宣佈推出 Applied Biosystems Axiom BloodGenomiX Array和軟體，用於在臨床研究中進行準確的血液基因分型。這種新陣列可以在一次檢測中檢測血小板類型、稀有血型和組織，有助於擴展表型捐贈者血液匹配的進步。基於 DNA 的血型檢測的增加預計將支持大規模基因組研究，並引入國際標準以提高輸血的有效性和安全性。增加基於可擴展陣列的血型解決方案的使用預計將能夠有效篩選不同的血型以進行準確匹配。

HLA 分型技術的進步支持市場擴張

領先的市場參與者和各種研究機構加強開發先進技術，預計將在未來幾年為市場提供利潤豐厚的成長機會。包括 PacBio 和 Illumina 在內的新一代定序 (NGS) 技術徹底改變了 HLA 分型，因為它們能夠對整個 HLA 基因（包括非編碼區和編碼區）進行定序。

2023 年 11 月，F. Hoffmann-La Roche Ltd 推出了下一代 qPCR 系統，以應對公共衛生課題並推動個人化醫療。LightCycler PRO System預計將透過為診斷和轉化研究提供靈活性和敏捷性來提供疫情回應能力。此外，2023年4月，Metropolis Healthcare Limited推出了NextGen HLA分型測試，透過分析HLA基因來識別適合器官移植、臍帶血和骨髓的捐贈者。NextGen HLA 分型測試預計將幫助醫生和患者確保移植後受者和供者之間 HLA 高度匹配，從而增加移植成功的可能性。

器官移植的增加推動 HLA 分型市場的成長

由於捐贈器官數量的增加而促使的器官移植數量的增加是推動全球 HLA 分型市場需求的主要因素之一。根據Organ Procurement and Transplantation Network（OPTN））的數據，2023年美國約有16,335人將在死亡時捐贈一個或多個器官，比2022年增加9.6%。器官捐贈的增加可歸因於人們對該程序及其對捐贈者健康影響的認識的提高。這促進了 HLA 匹配的需求，因為它降低了與移植後併發症相關的風險，並促進健康新血球的發育和生長。捐贈者和接受者必須至少在六個 HLA 標記上配對。不匹配程度越高，患者的免疫系統就越有可能產生抗體來攻擊移植物。

本報告針對全球HLA分型市場進行研究分析，提供市場規模及預測、區域市場前景、市場動態、競爭格局等。

目錄

第1章 專案範圍與定義

第2章 研究方法

第3章 執行摘要

第4章 全球HLA分型市場展望（2017-2031）

  • 市場規模分析與預測
    • 金額
    • 數量
  • 市佔率分析及預測
    • 按產品/服務
    • 按技術
    • 按用途
    • 按最終用戶
    • 按地區
    • 市場佔有率分析：按公司劃分（金額）（前 5 名公司及其他 - 2023 年）
  • 市場地圖分析（2023）
    • 按產品/服務
    • 按技術
    • 按用途
    • 按最終用戶
    • 按地區

第五章 北美HLA分型市場展望（2017-2031）

  • 市場規模分析與預測
    • 金額
    • 數量
  • 市佔率分析及預測
    • 按產品/服務
    • 按技術
    • 按用途
    • 按最終用戶
    • 分享：按國家/地區
  • 市場評估：依國家分類
    • 美國HLA分型市場前景，2017-2031年預測
    • 加拿大
    • 墨西哥

第六章 歐洲HLA分型市場展望（2017-2031）

  • 德國
  • 法國
  • 義大利
  • 英國
  • 俄羅斯
  • 荷蘭
  • 西班牙
  • 波蘭

第七章亞太HLA分型市場展望（2017-2031）

  • 印度
  • 中國
  • 日本
  • 澳大利亞
  • 越南
  • 韓國
  • 印度尼西亞
  • 菲律賓

第八章 南美HLA分型市場展望（2017-2031）

  • 巴西
  • 阿根廷

第九章 中東和非洲HLA分型市場展望（2017-2031）

  • 沙烏地阿拉伯
  • 阿拉伯聯合酋長國
  • 南非
  • 以色列

第10章 供需分析

第11章 進出口分析

第12章 價值鏈分析

第13章波特五力分析

第14章 PESTLE分析

第15章 價格分析

第16章 市場動態

  • 市場驅動力
  • 市場課題

第 17 章市場趨勢和發展

第18章 監理框架與創新

  • 臨床試驗
  • 監管審批

第19章 專利情況

第20章 案例研究

第21章 競爭格局

  • 前5名市場領導者的競爭矩陣
  • 前5名企業SWOT分析
  • 前10名主要企業狀況
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • QIAGEN N.V.
    • F. Hoffmann-La Roche Ltd
    • bioMerieux SA
    • Illumina, Inc.
    • Becton, Dickinson and Company
    • Omixon Inc.
    • Takara Bio Inc.
    • TBG Diagnostics Limited

第22章 戰略建議

第23章 關於我們公司、免責聲明

Product Code: MX11677

Global HLA typing market is projected to witness a CAGR of 6.27% during the forecast period 2024-2031, growing from USD 1.31 billion in 2023 to USD 2.13 billion in 2031. The market's growth is supported by the rising requirement for organ transplantation, increasing cases of genetic diseases, growing emphasis on research activities, and novel product launches by the leading players of the market.

According to the estimates of the Health Resource and Services Administration (HRSA) approximately 103,223 men, women, and children are on the national transplant waiting list in the United States. Due to this increase, the cases of organ transplant procedures are rising, bolstering the requirement for HLA typing. The global HLA typing market size is increasing due to the rising research activities on genetic and autoimmune diseases due to their growing burden. According to the estimates of the American Autoimmune, approximately 50 million Americans are living with one or more autoimmune diseases.

The development of novel technologies, products, and software by the leading players in the market is providing lucrative growth opportunities to the market. In June 2024, Thermo Fisher Scientific Inc. introduced their Applied Biosystems Axiom BloodGenomiX Array and software for precise blood genotyping in clinical research. The new array is capable of detecting platelet types, rare blood groups, and tissues in a single assay, aiding advancements in extended phenotype donor blood matching. Increasing utilization of DNA-based blood typing is expected to support large-scale genomics research and the introduction of international standards for improving the efficacy and safety of blood transfusion. The increasing accessibility of scalable array-based blood typing solutions is expected to effectively screen various blood types for precise matching.

Technological Advancements in HLA Typing Support the Market Expansion

The increasing efforts of the key players of the market and various research institutions toward the development of advanced technologies are expected to provide lucrative growth opportunities to the market in the forecast years. Next-generation sequencing (NGS) technologies, including PacBio and Illumina, have revolutionized HLA typing as they enable the sequencing of entire HLA genes, including noncoding and coding regions.

In November 2023, F. Hoffmann-La Roche Ltd launched a next-generation qPCR system to address public health challenges and advance personalized healthcare. The LightCycler PRO System is expected to provide outbreak readiness by providing flexibility and agility for diagnostics and translational research. Additionally, in April 2023, Metropolis Healthcare Limited launched their NextGen HLA typing test for identifying suitable donors for organ transplantation, cord blood, and bone marrow by analyzing the HLA gene. The NextGen HLA typing test is expected to aid physicians, doctors, and patients in ensuring transplants at a higher HLA match percentage between the recipient and the donor, bolstering the chances of successful transplants.

Increasing Organ Transplantation Boosts HLA Typing Market Growth

The rise in organ transplant procedures due to the increasing availability of donated organs is one of the major factors bolstering the global HLA typing market demand. According to the Organ Procurement and Transplantation Network (OPTN), in 2023, approximately 16,335 individuals donated one or more organs upon their death in the United States, showcasing a 9.6% increase from 2022. The increasing donations can be attributed to the growing awareness about the procedure and the impact of the donation on donor health. This propels the requirement for HLA matching as it reduces the risks associated with post-transplant complications and promotes the development and growth of healthy new blood cells. Donors and recipients should have a match of at least 6 HLA markers, as a high degree of mismatch augments the chances of antibody production from the immune system of the patient, which can attack the graft.

Diagnostics Segment Expected to Witness Significant Growth

The growth of the segment is supported by the rising requirement for organ transplantation and increasing cases of autoimmune and genetic diseases. For instance, the HLA-B27 test is conducted to confirm or dismiss suspected cases of ankylosing spondylitis (AS), juvenile rheumatoid arthritis, and reactive arthritis. The test aids healthcare professionals in determining the presence or absence of the HLA-B27 protein on the surface of the white blood cells in individuals. Additionally, the expansion of the segment is supported by the rising collaborations between different diagnostic and biotech companies to support the development of HLA typing kits. In November 2023, OSE Immunotherapeutics and GenDx announced the partnership for developing NGSengine software and NGSgo HLA-A typing kit as a companion diagnostic (CDx) for cancer vaccines. With the partnership, the companies aim to validate and develop a CDx test for epitope-based cancer vaccines to improve the survival and the quality of patients' lives.

North America Holds Significant Market Share

The presence of leading market players, rising requirements for organ transplantation in the region, novel product launches, and presence of well-established healthcare infrastructure are some of the major factors boosting the market's growth. According to estimates from the United Network for Organ Sharing (UNOS), in 2023 over 46,000 organ transplants were performed in the United States. This increase propels the market demand as HLA typing is one of the essential components for matching hematopoietic cells between the recipients and the donors for improving patient outcomes by aiding patients in avoiding graft-versus-host disease (GVHD) and acute graft rejection.

The strong presence of various research institutions and increasing investments in research activities are another significant factors supporting the market's expansion. For instance, the Memorial Sloan Kettering Cancer Center is conducting an interventional study to evaluate if the addition of specific genetic factors to the process of selecting a stem cell donor reduces the chances of leukemia coming back in patients after the bone marrow has been transplanted. The study is expected to conclude in May 2025 and aims to demonstrate that patients with adult acute myeloid leukemia (AML) who have donors with specific HLA and killer immunoglobulin-like receptors (KIR) genes have better outcomes.

Future Market Scenario (2024 - 2031F)

Market demand is expected to increase significantly over the forecast period due to the rise in the number of organ transplantations. Advancements in bioinformatics and nanopore technology are expected to enhance the efficiency, speed, and reliability of HLA genotyping, revolutionizing their clinical applications and immunogenetics.

The increasing autoimmune diseases incidences are bolstering the requirement for HLA typing, as it can provide insights about various risks of autoimmune diseases and guide the development of prophylactic interventions for reducing the risks in individuals that are susceptible to the disease.

The growing efforts of the key market players towards the development of novel technologies and products is another major factor expected to boost the growth of the market in the coming years.

Key Players Landscape and Outlook

The rising efforts of the key players of the market towards the development of novel products and technologies and increasing receival of approvals from various regulatory bodies are supporting the global HLA typing market growth. These efforts and approvals aid healthcare professionals in accurately diagnosing various diseases and disorders and support the introduction of new products to meet the evolving requirements of the healthcare industry.

In December 2022, Thermo Fisher Scientific Inc. announced that they received De Novo Classification from the US Food and Drug Administration (FDA) for their SeCore CDx HLA Sequencing System, the system allows clinicians to identify patients that will benefit from this immunotherapy breakthrough. The company plans on partnering with leading companies for commercializing and developing immunotherapies for meeting the unmet requirements of patients for a wide range of diseases.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global HLA Typing Market Outlook, 2017-2031F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Products and Services
      • 4.2.1.1. Instruments
      • 4.2.1.2. Reagents and Consumables
      • 4.2.1.3. Software and Services
    • 4.2.2. By Technology
      • 4.2.2.1. Molecular Assays
        • 4.2.2.1.1. Sequencing-based Molecular Assays
          • 4.2.2.1.1.1. Sanger Sequencing
          • 4.2.2.1.1.2. Next-generation Sequencing
          • 4.2.2.1.1.3. Pyrosequencing
        • 4.2.2.1.2. PCR-based Molecular Assays
          • 4.2.2.1.2.1. Sequence-specific Primer-PCR
          • 4.2.2.1.2.2. Sequence-specific Oligonucleotide-PCR
          • 4.2.2.1.2.3. Others
      • 4.2.2.2. Non-molecular Assays
    • 4.2.3. By Application
      • 4.2.3.1. Diagnostics
        • 4.2.3.1.1. Infectious Diseases Diagnostics
        • 4.2.3.1.2. Cancer Diagnosis and Prevention
        • 4.2.3.1.3. Transmission Therapy
        • 4.2.3.1.4. Donor Recipient Cross-Matching
      • 4.2.3.2. Research
    • 4.2.4. By End-user
      • 4.2.4.1. Hospitals and Transplant Centers
      • 4.2.4.2. Commercial Service Providers
      • 4.2.4.3. Research Labs and Academic Institutes
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia-Pacific
      • 4.2.5.4. South America
      • 4.2.5.5. Middle East and Africa
    • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 4.3. Market Map Analysis, 2023
    • 4.3.1. By Products and Services
    • 4.3.2. By Technology
    • 4.3.3. By Application
    • 4.3.4. By End-user
    • 4.3.5. By Region

5. North America HLA Typing Market Outlook, 2017-2031F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
    • 5.1.2. By Volume
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Products and Services
      • 5.2.1.1. Instruments
      • 5.2.1.2. Reagents and Consumables
      • 5.2.1.3. Software and Services
    • 5.2.2. By Technology
      • 5.2.2.1. Molecular Assays
        • 5.2.2.1.1. Sequencing-based Molecular Assays
          • 5.2.2.1.1.1. Sanger Sequencing
          • 5.2.2.1.1.2. Next-generation Sequencing
          • 5.2.2.1.1.3. Pyrosequencing
        • 5.2.2.1.2. PCR-based Molecular Assays
          • 5.2.2.1.2.1. Sequence-specific Primer-PCR
          • 5.2.2.1.2.2. Sequence-specific Oligonucleotide-PCR
          • 5.2.2.1.2.3. Others
      • 5.2.2.2. Non-molecular Assays
    • 5.2.3. By Application
      • 5.2.3.1. Diagnostics
        • 5.2.3.1.1. Infectious Diseases Diagnostics
        • 5.2.3.1.2. Cancer Diagnosis and Prevention
        • 5.2.3.1.3. Transmission Therapy
        • 5.2.3.1.4. Donor Recipient Cross-Matching
      • 5.2.3.2. Research
    • 5.2.4. By End-user
      • 5.2.4.1. Hospitals and Transplant Centers
      • 5.2.4.2. Commercial Service Providers
      • 5.2.4.3. Research Labs and Academic Institutes
    • 5.2.5. By Country Share
      • 5.2.5.1. United States
      • 5.2.5.2. Canada
      • 5.2.5.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States HLA Typing Market Outlook, 2017-2031F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
        • 5.3.1.1.2. By Volume
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Products and Services
          • 5.3.1.2.1.1. Instruments
          • 5.3.1.2.1.2. Reagents and Consumables
          • 5.3.1.2.1.3. Software and Services
        • 5.3.1.2.2. By Technology
          • 5.3.1.2.2.1. Molecular Assays
          • 5.3.1.2.2.1.1. Sequencing-based Molecular Assays
          • 5.3.1.2.2.1.1.1. Sanger Sequencing
          • 5.3.1.2.2.1.1.2. Next-generation Sequencing
          • 5.3.1.2.2.1.1.3. Pyrosequencing
          • 5.3.1.2.2.1.2. PCR-based Molecular Assays
          • 5.3.1.2.2.1.2.1. Sequence-specific Primer-PCR
          • 5.3.1.2.2.1.2.2. Sequence-specific Oligonucleotide-PCR
          • 5.3.1.2.2.1.2.3. Others
          • 5.3.1.2.2.2. Non-molecular Assays
        • 5.3.1.2.3. By Application
          • 5.3.1.2.3.1. Diagnostics
          • 5.3.1.2.3.1.1. Infectious Diseases Diagnostics
          • 5.3.1.2.3.1.2. Cancer Diagnosis and Prevention
          • 5.3.1.2.3.1.3. Transmission Therapy
          • 5.3.1.2.3.1.4. Donor Recipient Cross-Matching
          • 5.3.1.2.3.2. Research
        • 5.3.1.2.4. By End-user
          • 5.3.1.2.4.1. Hospitals and Transplant Centers
          • 5.3.1.2.4.2. Commercial Service Providers
          • 5.3.1.2.4.3. Research Labs and Academic Institutes
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe HLA Typing Market Outlook, 2017-2031F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific HLA Typing Market Outlook, 2017-2031F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America HLA Typing Market Outlook, 2017-2031F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa HLA Typing Market Outlook, 2017-2031F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

  • 16.1. Market Drivers
  • 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

  • 18.1. Clinical Trials
  • 18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

  • 21.1. Competition Matrix of Top 5 Market Leaders
  • 21.2. SWOT Analysis for Top 5 Players
  • 21.3. Key Players Landscape for Top 10 Market Players
    • 21.3.1. Thermo Fisher Scientific Inc.
      • 21.3.1.1. Company Details
      • 21.3.1.2. Key Management Personnel
      • 21.3.1.3. Products and Services
      • 21.3.1.4. Financials (As Reported)
      • 21.3.1.5. Key Market Focus and Geographical Presence
      • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 21.3.2. Bio-Rad Laboratories, Inc.
    • 21.3.3. QIAGEN N.V.
    • 21.3.4. F. Hoffmann-La Roche Ltd
    • 21.3.5. bioMerieux SA
    • 21.3.6. Illumina, Inc.
    • 21.3.7. Becton, Dickinson and Company
    • 21.3.8. Omixon Inc.
    • 21.3.9. Takara Bio Inc.
    • 21.3.10. TBG Diagnostics Limited

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 3. Global HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 4. Global HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 5. Global HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 6. Global HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global HLA Typing Market Share (%), By Region, 2017-2031F
  • Figure 8. North America HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 9. North America HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 10. North America HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 11. North America HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 12. North America HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 13. North America HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America HLA Typing Market Share (%), By Country, 2017-2031F
  • Figure 15. United States HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. United States HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 17. United States HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 18. United States HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 19. United States HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 20. United States HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 22. Canada HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 23. Canada HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 24. Canada HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 25. Canada HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 26. Canada HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 28. Mexico HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 29. Mexico HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 30. Mexico HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 31. Mexico HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 32. Mexico HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 34. Europe HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 35. Europe HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 36. Europe HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 37. Europe HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 38. Europe HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe HLA Typing Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. Germany HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 42. Germany HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 43. Germany HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 44. Germany HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 45. Germany HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 46. France HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. France HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 48. France HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 49. France HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 50. France HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 51. France HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Italy HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 54. Italy HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 55. Italy HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 56. Italy HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 57. Italy HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 59. United Kingdom HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 60. United Kingdom HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 61. United Kingdom HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 62. United Kingdom HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 63. United Kingdom HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Russia HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 66. Russia HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 67. Russia HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 68. Russia HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 69. Russia HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 71. Netherlands HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 72. Netherlands HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 73. Netherlands HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 74. Netherlands HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 75. Netherlands HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. Spain HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 78. Spain HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 79. Spain HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 80. Spain HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 81. Spain HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. Turkey HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 84. Turkey HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 85. Turkey HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 86. Turkey HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 87. Turkey HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Poland HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 90. Poland HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 91. Poland HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 92. Poland HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 93. Poland HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. South America HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 96. South America HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 97. South America HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 98. South America HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 99. South America HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America HLA Typing Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. Brazil HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 103. Brazil HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 104. Brazil HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 105. Brazil HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 106. Brazil HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 108. Argentina HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 109. Argentina HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 110. Argentina HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 111. Argentina HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 112. Argentina HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 114. Asia-Pacific HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 115. Asia-Pacific HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 116. Asia-Pacific HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 117. Asia-Pacific HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 118. Asia-Pacific HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific HLA Typing Market Share (%), By Country, 2017-2031F
  • Figure 120. India HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 121. India HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 122. India HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 123. India HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 124. India HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 125. India HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 126. China HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. China HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 128. China HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 129. China HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 130. China HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 131. China HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 133. Japan HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 134. Japan HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 135. Japan HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 136. Japan HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 137. Japan HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 139. Australia HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 140. Australia HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 141. Australia HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 142. Australia HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 143. Australia HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 145. Vietnam HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 146. Vietnam HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 147. Vietnam HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 148. Vietnam HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 149. Vietnam HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 151. South Korea HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 152. South Korea HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 153. South Korea HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 154. South Korea HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 155. South Korea HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 157. Indonesia HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 158. Indonesia HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 159. Indonesia HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 160. Indonesia HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 161. Indonesia HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 163. Philippines HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 164. Philippines HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 165. Philippines HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 166. Philippines HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 167. Philippines HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 169. Middle East & Africa HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 170. Middle East & Africa HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 171. Middle East & Africa HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 172. Middle East & Africa HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 173. Middle East & Africa HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa HLA Typing Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Saudi Arabia HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 177. Saudi Arabia HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 178. Saudi Arabia HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 179. Saudi Arabia HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 180. Saudi Arabia HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. UAE HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 183. UAE HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 184. UAE HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 185. UAE HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 186. UAE HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa HLA Typing Market, By Value, In USD Billion, 2017-2031F
  • Figure 188. South Africa HLA Typing Market, By Volume, In Million Units, 2017-2031F
  • Figure 189. South Africa HLA Typing Market Share (%), By Products and Services, 2017-2031F
  • Figure 190. South Africa HLA Typing Market Share (%), By Technology, 2017-2031F
  • Figure 191. South Africa HLA Typing Market Share (%), By Application, 2017-2031F
  • Figure 192. South Africa HLA Typing Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Products and Services Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023